citalopram has been researched along with Hypochondriacal Neuroses in 4 studies
Citalopram: A furancarbonitrile that is one of the serotonin uptake inhibitors used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic antidepressants, which aggravate dyskinesia.
citalopram : A racemate comprising equimolar amounts of (R)-citalopram and its enantiomer, escitalopram. It is used as an antidepressant, although only escitalopram is active.
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile : A nitrile that is 1,3-dihydro-2-benzofuran-5-carbonitrile in which one of the hydrogens at position 1 is replaced by a p-fluorophenyl group, while the other is replaced by a 3-(dimethylamino)propyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Citalopram was delivered using measurement-based care and flexible dosing with the aim of achieving symptom remission." | 2.74 | Sociodemographic, clinical, and treatment characteristics associated with worsened depression during treatment with citalopram: results of the NIMH STAR(*)D trial. ( Balasubramani, GK; Fava, M; Friedman, ES; Gilmer, W; Nierenberg, AA; Rush, AJ; Trivedi, MH; Wisniewski, SR; Zisook, S, 2009) |
| "All of the patients with primary conversion disorder had a current or previous depressive or anxiety disorder compared with 40% (N = 2) of the patients with additional somatoform diagnoses." | 2.71 | Antidepressant treatment outcomes of psychogenic movement disorder. ( Lang, AE; Voon, V, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gkini, MA | 1 |
| Taylor, RE | 1 |
| Bewley, AP | 1 |
| Friedman, ES | 1 |
| Wisniewski, SR | 1 |
| Gilmer, W | 1 |
| Nierenberg, AA | 1 |
| Rush, AJ | 1 |
| Fava, M | 1 |
| Zisook, S | 1 |
| Balasubramani, GK | 1 |
| Trivedi, MH | 1 |
| Talarowska, M | 1 |
| Zboralski, K | 1 |
| Chamielec, M | 1 |
| Gałecki, P | 1 |
| Voon, V | 1 |
| Lang, AE | 1 |
2 trials available for citalopram and Hypochondriacal Neuroses
| Article | Year |
|---|---|
Sociodemographic, clinical, and treatment characteristics associated with worsened depression during treatment with citalopram: results of the NIMH STAR(*)D trial.
Topics: Adolescent; Adult; Aged; Black or African American; Citalopram; Demography; Depressive Disorder, Maj | 2009 |
Antidepressant treatment outcomes of psychogenic movement disorder.
Topics: Adult; Ambulatory Care; Anxiety Disorders; Chronic Disease; Citalopram; Combined Modality Therapy; C | 2005 |
2 other studies available for citalopram and Hypochondriacal Neuroses
| Article | Year |
|---|---|
Olfactory reference syndrome (ORS) successfully treated with a selective serotonin reuptake inhibitor.
Topics: Citalopram; Diagnostic and Statistical Manual of Mental Disorders; Humans; Hypochondriasis; Male; Od | 2017 |
The MMPI-2 neurotic triad subscales and depression levels after pharmacological treatment in patients with depressive disorders - clinical study.
Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder; Female; Fluoxetine; Humans; Hypochond | 2011 |